14.07.2013 Views

Cover Letter for NCI Consent Form Template - Cancer Therapy ...

Cover Letter for NCI Consent Form Template - Cancer Therapy ...

Cover Letter for NCI Consent Form Template - Cancer Therapy ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

The dedicated ef<strong>for</strong>ts of the Working Group members who prepared this version of the <strong>Template</strong><br />

are greatly appreciated. Their names are also posted on the CTEP website. Additional helpful<br />

documents posted on the CTEP website, in the “In<strong>for</strong>med <strong>Consent</strong>” section found under the<br />

“Protocol Development” tab include:<br />

<strong>Consent</strong> <strong>for</strong>m example <strong>for</strong> a Phase 2 treatment trial, written using revised <strong>Template</strong><br />

<strong>Consent</strong> <strong>for</strong>m example <strong>for</strong> a Phase 3 treatment trial, written using revised <strong>Template</strong><br />

<strong>Letter</strong> of rationale addressed to IRB Chairs and Members<br />

Instructions <strong>for</strong> building “Tables of Possible Side Effects”<br />

<strong>NCI</strong> Scientific Term CTCAE – IC Term Spreadsheet 12-12-12<br />

Repository of “Tables” <strong>for</strong> commonly-used commercials drugs<br />

Repository of “Tables” <strong>for</strong> commonly-used regimens (to be added within the year)<br />

CTEP will begin using the February 15, 2013 version of the <strong>Template</strong> <strong>for</strong> review of your consent<br />

<strong>for</strong>m documents as of May 15, 2013. Please utilize the February 15, 2013 version of the<br />

<strong>Template</strong> to guide preparation of consent <strong>for</strong>m documents on all new protocol submissions to<br />

<strong>NCI</strong> as soon as possible.<br />

Your support of more concise consent <strong>for</strong>ms is appreciated and assists the <strong>NCI</strong> to better in<strong>for</strong>m<br />

prospective study participants.<br />

Best regards,<br />

Jeffrey Abrams, M.D.<br />

Associate Director, <strong>Cancer</strong> <strong>Therapy</strong> Evaluation Program<br />

Acting Director <strong>for</strong> Clinical Research<br />

Division of <strong>Cancer</strong> Treatment and Diagnosis<br />

National <strong>Cancer</strong> Institute<br />

Page 2 of 2

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!